Package Leaflet: Information for the User
Latanoprost Farmalider 50 micrograms/ml eye drops, solution
Latanoprost
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Latanoprost belongs to a group of medicines known as prostaglandin analogues.
It works by increasing the natural outflow of fluid from the eye into the bloodstream.
Latanoprost is used to treat diseases such as open-angle glaucoma and ocular hypertensionin adults. Both of these diseases cause increased pressure in the eye due to the build-up of fluid.
Latanoprost is also used to treat increased pressure in the eye and glaucoma in children and infants of all ages.
Latanoprost can be used in adult men and women (including the elderly) and in children from birth to 18 years of age. Latanoprost Farmalider has not been studied in premature infants (less than 36 weeks gestation).
Do not use Latanoprost Farmalider:
Warnings and precautionsConsult your doctor or your child's doctor or pharmacist before starting to use Latanoprost Farmalider or before giving it to your child:
Using Latanoprost Farmalider with other medicines
Latanoprost may interact with other medicines. Tell your doctor, your child's doctor or pharmacist if you or your child are using, have recently used or might use any other medicines.
Pregnancy and breast-feeding
Do not use Latanoprost during pregnancy or while breast-feeding.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
When using Latanoprost, blurred vision may occur for a short time. If this happens, do not drive or use tools or machines until your vision is clear again.
Latanoprost contains benzalkonium chloride.
Latanoprost contains a preservative called benzalkonium chloride.
Benzalkonium chloride can be absorbed by soft contact lenses and may change the color of the contact lenses. You should remove your contact lenses before using this medicine and wait 15 minutes before putting them back in. Follow the instructions in section 3 for contact lens wearers.
Benzalkonium chloride may cause eye irritation, especially if you have dry eyes or other corneal problems (the transparent layer on the front of the eye). Consult your doctor if you feel any unusual sensation, itching or pain in the eye after using this medicine.
Follow exactly the instructions given to you by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
If you are unsure, consult your doctor or your child's doctor or pharmacist again.
The recommended dose for adults (including the elderly) and children is one drop in the affected eye(s) once daily. It is best to administer it in the evening.
Do not use Latanoprost Farmalider more than once daily; the effectiveness of the treatment may decrease if it is administered more frequently.
Use Latanoprost Farmalider as your doctor or your child's doctor has told you until they tell you to stop.
Contact lens wearers
If you or your child wear contact lenses, you must remove them before using this medicine.
After applying this medicine, wait 15 minutes before putting your contact lenses back in.
Instructions for use
If you use this medicine with other eye drops
Wait at least 5 minutes between using Latanoprost Farmalider and applying (or using) other eye drops.
If you use more Latanoprost Farmalider than you should
If you have applied more drops in the eye than you should, you may feel a slight irritation in the eye and your eyes may become red and watery; this should go away, but if you are concerned, consult your doctor or your child's doctor.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to use Latanoprost Farmalider
Continue with the administration of the next dose as usual. Do not apply an extra drop in the eye to make up for the missed dose. If you are unsure, consult your doctor or pharmacist.
If you stop using Latanoprost Farmalider
If you want to stop using Latanoprost Farmalider, consult your doctor or your child's doctor.
If you have any other questions about the use of this medicine, ask your doctor or your child's doctor or pharmacist.
Like all medicines, Latanoprost Farmalider can cause side effects, although not everybody gets them.
The following are side effects of using Latanoprost Farmalider eye drops:
Very common side effects(may affect more than 1 in 10 people):
treated, observed in most patients of Japanese origin. These changes include an increase in color (darkening), length, thickness and number of eyelashes.
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Swelling of the eyelids, dry eye, inflammation or irritation of the surface of the eye (keratitis), blurred vision, inflammation of the colored part of the eye (uveitis), inflammation of the retina (macular edema)
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect up to 1 in 10,000 people):
Worsening of angina in patients who also have heart problems, sunken appearance of the eyes (deepening of the orbital sulcus)
Other side effects in children
Side effects observed in children at a higher frequency than in adults are runny nose and itchy nose and fever.
In very rare cases, some patients with severe damage to the transparent layer on the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium deposits during treatment.
If you experience side effects, consult your doctor, your child's doctor or pharmacist, even if it is a possible side effect not listed in this leaflet.
Reporting of side effects
If you experience any side effects, consult your doctor or nurse, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and bottle.
The expiry date is the last day of the month stated.
Store the unopened bottle in the refrigerator (between 2°C and 8°C) to protect it from light.
Once the bottle is opened, it is not necessary to store it in the refrigerator, but do not store it above 25°C. It must be used within 4 weeks of opening. When not using Latanoprost, keep the bottle in the outer packaging to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Latanoprost Farmalider
The active substance is latanoprost.
1 ml of solution contains 50 micrograms of latanoprost.
The other ingredients (excipients) are: benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, disodium phosphate anhydrous, water for injections.
Appearance of the product and pack contents
Latanoprost eye drops, solution is a clear, colorless liquid.
Latanoprost is available in pack sizes of 1, 3 and 6 units.
Not all pack sizes may be marketed.
Each unit contains one bottle of Latanoprost. Each bottle contains 2.5 ml of Latanoprost eye drops, solution.
Marketing authorisation holder and manufacturer:
Marketing authorisation holder:
Farmalider, S.A.
C/ La Granja, 1
28108 Alcobendas (Madrid)
Spain
Manufacturer:
FDC International Ltd.,
Unit 6, Fulcrum 1, Solent Way, Whiteley, Fareham, Hampshire, PO15 7FE, UK
Date of last revision of this leaflet:March 2022.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/